SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

CytoDyn Inc. (CYDY) News

Track canonical SquawkNews coverage tagged to CYDY, CytoDyn Inc.. This hub brings together deduplicated headlines about otc markets otcqb, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol CYDY Asset equity Sector Markets 90 days 1 Last 0.2303 Updated Sep 01, 2026, 12:37 PM UTC Open live news feed
L CytoDyn closes $16.5 million financing to fund leronlimab development CytoDyn says it has closed a $16.5 million financing to fund continued development of leronlimab, its humanized monoclonal antibody targeting the CCR5 receptor. EQUITY | Sep 01, 2026, 12:37 PM UTC